Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Total 13F shares
-
11,381,595
-
Share change
-
+11,134,950
-
Total reported value
-
$471,486,114
-
Price per share
-
$41.50
-
Number of holders
-
45
-
Value change
-
+$461,249,860
-
Number of buys
-
44
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2015
As of 30 Jun 2015,
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,381,595 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Advisors LLC, Flagship Ventures 2007 General Partner LLC, TimesSquare Capital Management, LLC, JENNISON ASSOCIATES LLC, Capital World Investors, WADDELL & REED FINANCIAL INC, RA CAPITAL MANAGEMENT, LLC, and ORBIMED ADVISORS LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.